Historical record - last NADAC publication: 6/21/2023
Product Information
QC OLOPATADINE 0.2% EYE DROP is a generic product labeled by Chain Drug Marketing Association, priced at $3.3397 per ML under NDC 63868082125. Its NADAC has been published 23 times since Jan 25, 2023.
The High Outlier badge above means this manufacturer's average price in the Olopatadine Hydrochloride Ophthalmic market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/mL
Manufacturer
Chain Drug Marketing AssociationNDC
63868082125
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Last Updated
6/21/2023
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209752On Market Since
1/1/2021
Pharmacological Classes
Price Statistics
The NADAC for QC OLOPATADINE 0.2% EYE DROP has been published 23 times since Jan 25, 2023, and over the history we have for it it has declined 15.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3397 per ML |
|---|---|
| All-time high | $3.9682 (Feb 15, 2023) |
| All-time low | $3.2995 (May 17, 2023) |
| Median price | $3.4968 |
| Average price | $3.5287 |
| Largest weekly change | -11.9% (Feb 22, 2023) |
| Weeks tracked | 23 |
| Tracking since | Jan 25, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC OLOPATADINE 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for QC OLOPATADINE 0.2% EYE DROP, manufactured by Chain Drug Marketing Association, is $3.3397 per ML (NDC 63868082125), effective Jun 28, 2023.
How has the price of QC OLOPATADINE 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for QC OLOPATADINE 0.2% EYE DROP has declined 15.8%. It has been tracked across 23 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for QC OLOPATADINE 0.2% EYE DROP?
Since Jan 25, 2023, the NADAC for QC OLOPATADINE 0.2% EYE DROP has ranged from a low of $3.2995 (May 17, 2023) to a high of $3.9682 (Feb 15, 2023), with a median of $3.4968 per ML.
Are there cheaper alternatives to QC OLOPATADINE 0.2% EYE DROP?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OLOPATADINE HCL 0.2% EYE DROP, is $2.9954 per ML — about 10% below QC OLOPATADINE 0.2% EYE DROP.
Who manufactures QC OLOPATADINE 0.2% EYE DROP?
QC OLOPATADINE 0.2% EYE DROP (NDC 63868082125) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification